Friday, April 27, 2018 7:18:29 AM
On April 24, 2018, the Registrant terminated the engagement of its Chief Financial Officer, J. Michael Tuohey. On April 24, 2018, the Registrant appointed R. Leslie Hymers, III, age 34, as its Chief Financial Officer. Mr. Hymers does not have a family relationship with any director, executive officer, or person nominated or chosen by the Registrant to become a director or executive officer.
Since the beginning of the Registrant's last fiscal year to the effective date of Mr. Hymers’ appointment, Mr. Hymers has not been a participant, nor has he had any direct or indirect material interest in any transaction in which the Company was or is to be a participant, and the amount involved exceeded $120,000.
Mr. Hymers agreed to render services as Chief Financial Officer to the Registrant. Mr. Hymers’ duties include but are not limited to: providing such services and fiduciary duties as are provided by a Chief Financial Officer of a publicly traded fully reporting company in compliance with the 1934 Securities and Exchange Act, the 2002 Sarbanes-Oxley Act, and the Rules and Regulations promulgated by the Securities and Exchange Commission. The Registrant agreed to compensate Mr. Hymers with a monthly fee of $6,000.00 and an annual cashless warrant to purchase common stock of $125,000. The Registrant also agreed to issue a one-time signing bonus of 50,000 shares of its restricted common stock, deemed earned as of April 24, 2018.
Recent AMMJ News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 05:23:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:27:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 06:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 01:42:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:08:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 06:36:07 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/21/2023 04:33:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 03:40:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:17:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 09:07:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:54:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:46:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:37:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/24/2023 05:51:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:02:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM